Clinical

The evidence, in one place.

QIKcap test data, the guidelines behind connector care, and tools for infection prevention, nursing and value analysis teams.

QIKcap studies

We tested the worst case.

Two independent in vitro studies evaluated QIKcap's microbial reduction on needleless connectors, using quantitative suspension methods with an organic soil load to simulate heavy clinical contamination.

QIKcap vs. IPA caps and scrubs alone (in vitro)

Pilot study, separate from the labeled result: with blood on the connector, a CHG/IPA scrub plus the 10-second QIKcap cycle measured a 4.95-log reduction of S. aureus, compared with 1.92 to 2.79 log for the cap and scrub arms. The FDA labeling reports a 4-log reduction under its own test conditions.

4-log IPA disinfecting cap1 min IPA scrub15 s CHG/IPA scrub5 s CHG/IPA scrub 5 s+ QIKcap 10 s 1.92 2.45 2.79 4.95 0123456 Log₁₀ reduction · S. aureus with bovine whole blood (mean of 3 connectors)

Six organisms in serum (statistically tested): CHG/IPA + QIKcap was significantly better than either scrub alone. Mean log reductions:

4.41

+ QIKcap

3.05

CHG/IPA scrub

2.63

IPA scrub

Chart: Montana State University Center for Biofilm Engineering, pilot study, May 2026. S. aureus ATCC 6538 on needleless connectors challenged with bovine whole blood; 3 connectors per arm; descriptive results without statistical testing. The IPA cap arm was wiped with an IPA pad for 8 s before the cap was applied. Six-organism results: CBE statistical report, Sept. 2025, organisms in 100% bovine serum, model-estimated pooled means including two fungal species; CHG/IPA + QIKcap was significantly better than either scrub alone (Tukey, p < 0.05). Laboratory results. Per FDA labeling, the device has not shown a significant reduction in fungal organisms, and a correlation to clinical infection-related outcomes has not been established.

Request

QIKcap Clinical Compendium

Methods, organisms, soil conditions and full results.

Request the Compendium

Ongoing research

Host a QIKcap study at your facility

We partner with hospitals and academic medical centers on connector-care research, from point-prevalence assessments to clinical pilots in ICU and acute-care units. Tell us about your units and research team.

Propose a research site